Asia-Pacific Liquid Biopsy Market to 2032
Overview
The Asia-Pacific Liquid Biopsy Market is expected to reach a 901.83 USD Billion by 2032 and is projected to grow at a CAGR of 18.53% from 2025 to 2032.
Revenue, 2024 (USD Billion)
311.12
Forecast, 2032 (USD Billion)
901.83
CAGR, 2024 - 2032
18.53%
Report Coverage
Asia-Pacific
Asia-Pacific Liquid Biopsy Market 2018-2032 USD Billion
Asia-Pacific Liquid Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 311.12 USD Billion
- Projected Market Size (2032): 901.83 USD Billion
- CAGR (2025-2032): 18.53%
Key Findings of Asia-Pacific Liquid Biopsy Market
- The Asia-Pacific Liquid Biopsy Market was valued at 311.12 USD Billion in 2024.
- The Asia-Pacific Liquid Biopsy Market is likely to grow at a CAGR of 18.53% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Multi-Gene-Parallel Analysis in Technology Segment accounted for the largest share of the market with a revenue of 254.51 USD Billion
- The fastest growing segment Routine Screening in Clinical Application Segment grew Fastest with a CAGR of 21.26% during the forecast period from 2024 to 2032.
Asia-Pacific Liquid Biopsy Market Scope
Asia-Pacific Liquid Biopsy Market Segmentation & Scope
Product
- Services & Software
- Instruments
- Consumables & Accessories
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Technology
- Single Gene Analysis
- Multi-Gene-Parallel Analysis
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Application
- Non-Cancer Applications
- Cancer Applications
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
Biomaker
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
- Circulating Tumor Cells (CTCS)
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
Asia-Pacific Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 311.12 USD Billion |
| Market Value in 2032 | 901.83 USD Billion |
| CAGR (2025-2032) | 18.53% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product,End User,Technology,Clinical Application,Application,Distribution Channel,Biomaker,Analytical,Sample |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 311.12 USD Billion in 2024
- Key Country: Japan, leading in terms of revenue with value of 89.51 USD Billion in 2024.
Segments and Scope
-
Asia-Pacific Liquid Biopsy Market to 2032, By Product
- Consumables & Accessories is the largest segment in Asia-Pacific Liquid Biopsy Market to 2032 with a revenue of 190.05 USD Billion in the year 2024.
- Consumables & Accessories is the Fastest growing segment in Asia-Pacific Liquid Biopsy Market to 2032 with a Growth rate of 19.29 % in forecast period 2025-2032.
-
Asia-Pacific Liquid Biopsy Market to 2032, By End User
- Hospitals is the largest segment in Asia-Pacific Liquid Biopsy Market to 2032 with a revenue of 200.38 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Asia-Pacific Liquid Biopsy Market to 2032 with a Growth rate of 19.33 % in forecast period 2025-2032.
-
Asia-Pacific Liquid Biopsy Market to 2032, By Technology
- Multi-Gene-Parallel Analysis is the largest segment in Asia-Pacific Liquid Biopsy Market to 2032 with a revenue of 254.51 USD Billion in the year 2024.
- Multi-Gene-Parallel Analysis is the Fastest growing segment in Asia-Pacific Liquid Biopsy Market to 2032 with a Growth rate of 19.06 % in forecast period 2025-2032.
-
Asia-Pacific Liquid Biopsy Market to 2032, By Clinical Application
- Routine Screening is the largest segment in Asia-Pacific Liquid Biopsy Market to 2032 with a revenue of 160.69 USD Billion in the year 2024.
- Routine Screening is the Fastest growing segment in Asia-Pacific Liquid Biopsy Market to 2032 with a Growth rate of 21.26 % in forecast period 2025-2032.
-
Asia-Pacific Liquid Biopsy Market to 2032, By Application
- Cancer Applications is the largest segment in Asia-Pacific Liquid Biopsy Market to 2032 with a revenue of 253.46 USD Billion in the year 2024.
- Cancer Applications is the Fastest growing segment in Asia-Pacific Liquid Biopsy Market to 2032 with a Growth rate of 19.00 % in forecast period 2025-2032.
-
Asia-Pacific Liquid Biopsy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Asia-Pacific Liquid Biopsy Market to 2032 with a revenue of 224.95 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Asia-Pacific Liquid Biopsy Market to 2032 with a Growth rate of 19.13 % in forecast period 2025-2032.
-
Asia-Pacific Liquid Biopsy Market to 2032, By Biomaker
- Circulating Tumor Cells (CTCS) is the largest segment in Asia-Pacific Liquid Biopsy Market to 2032 with a revenue of 153.43 USD Billion in the year 2024.
- Circulating Tumor Cells (CTCS) is the Fastest growing segment in Asia-Pacific Liquid Biopsy Market to 2032 with a Growth rate of 20.69 % in forecast period 2025-2032.
-
Asia-Pacific Liquid Biopsy Market to 2032, By Analytical
- Molecular is the largest segment in Asia-Pacific Liquid Biopsy Market to 2032 with a revenue of 199.99 USD Billion in the year 2024.
- Proteomic is the Fastest growing segment in Asia-Pacific Liquid Biopsy Market to 2032 with a Growth rate of 19.20 % in forecast period 2025-2032.
-
Asia-Pacific Liquid Biopsy Market to 2032, By Sample
- Blood Sample-Based is the largest segment in Asia-Pacific Liquid Biopsy Market to 2032 with a revenue of 195.12 USD Billion in the year 2024.
- Blood Sample-Based is the Fastest growing segment in Asia-Pacific Liquid Biopsy Market to 2032 with a Growth rate of 19.63 % in forecast period 2025-2032.
Asia-Pacific Liquid Biopsy Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Guardant Health | |||
| Exact Sciences Corporation | |||
| F. Hoffmann-La Roche Ltd. | |||
Asia-Pacific Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Billion
Asia-Pacific Liquid Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Liquid Biopsy Market is segmented based on Segmentation Product,End User,Technology,Clinical Application,Application,Distribution Channel,Biomaker,Analytical,Sample.
Asia-Pacific Liquid Biopsy Market was valued at USD 311.12(Revenue in USD Billion) in 2021.
Asia-Pacific Liquid Biopsy Market is projected to grow at a CAGR of 18.53% during the forecast period of 2024 to 2032.
The Multi-Gene-Parallel Analysis segment is expected to dominate the Asia-Pacific Liquid Biopsy Market, holding a largest market share of 254.51 USD Billion in 2024
Asia-Pacific Liquid Biopsy Market Scope
Asia-Pacific Liquid Biopsy Market Segmentation & Scope
Product
- Services & Software
- Instruments
- Consumables & Accessories
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Technology
- Single Gene Analysis
- Multi-Gene-Parallel Analysis
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Application
- Non-Cancer Applications
- Cancer Applications
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
Biomaker
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
- Circulating Tumor Cells (CTCS)
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
Frequently Asked Questions
The Asia-Pacific Liquid Biopsy Market is segmented based on Segmentation Product,End User,Technology,Clinical Application,Application,Distribution Channel,Biomaker,Analytical,Sample.
Asia-Pacific Liquid Biopsy Market was valued at USD 311.12(Revenue in USD Billion) in 2021.
Asia-Pacific Liquid Biopsy Market is projected to grow at a CAGR of 18.53% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Liquid Biopsy Market for final year is USD 901.83 (USD Billion).
Asia-Pacific Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Liquid Biopsy Market is segmented based on Segmentation Product,End User,Technology,Clinical Application,Application,Distribution Channel,Biomaker,Analytical,Sample.
Asia-Pacific Liquid Biopsy Market was valued at USD 311.12(Revenue in USD Billion) in 2021.
Asia-Pacific Liquid Biopsy Market is projected to grow at a CAGR of 18.53% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Liquid Biopsy Market for final year is USD 901.83 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.